The New South Wales Racing Laboratory has developed a test to detect the drug erythropoietin, commonly known as EPO, in racehorses, according to release on the Racing New South Wales Web site. The medication is considered a performance-enhancer.
Tony Hartnell, chairman of the New South Wales Thoroughbred Racing Board, said development of the test is a major scientific achievement and
To continue reading this article, become a member of TheHorse.com.
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.
